In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

From Bed to Bench: An Interview with Stephen Oesterle

Executive Summary

Stephen Oesterle's mandate as senior vice president, medicine and technology and chief medical officer at Medtronic is nothing less than to help Medtronic chart a future course as technology and clinical developments force further change on the medical device industry. And daunting as that project is, few people appear better equipped for the challenge than Oesterle, who is known for his ability to combine an analytic mind with a capacious imagination-a combination well suited to embracing all aspects of the nexus of medicine and technology. This includes the convergence of medical technology and biotechnology, an area in which Oesterle has done as much as anyone in the industry to make happen for device companies.

You may also be interested in...



Medtronic: Doing Just What the Doctors Order

Medtronic has recruited physician opinion leaders for strategic management positions in most of its operating divisions. The company believes this strategy will help bring them closer to customers and expedite the bedside-to-bench process for developing new products.

Building Medtronic Neuro by Trial: An Interview with Richard Kuntz, MD

Medtronic is the acknowledged leader in one of the hottest device sectors-neurostimulation-but even this giant struggles with problems of limited market penetration. So Medtronic is bringing a new approach to this area: an aggressive clinical trials strategy to differentiate its products and drive physician adoption. Who better to run the business than a clinical trials expert? Richard Kuntz talks about future neuro opportunities and the current challenges facing device clinical trials.

The Device Industry's Training Ground

Are successful medical device start-ups born or made? It's not clear, but Stanford University's Emerging Entrepreneur program is attempting to incorporate the experience of successful start-ups in a hnew learning program.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

IV002958

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel